Marc Schegerin - Mar 7, 2023 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
CFO and COO
Signature
/s/ Robert Farrell as attorney-in-fact for Marc Schegerin
Stock symbol
MORF
Transactions as of
Mar 7, 2023
Transactions value $
-$1,400,060
Form type
4
Date filed
3/9/2023, 05:59 PM
Previous filing
Jan 18, 2023
Next filing
Apr 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise $750K +50K +292.84% $15.00 67.1K Mar 7, 2023 Direct F1
transaction MORF Common Stock Sale -$2.25M -50K -74.54% $45.00 17.1K Mar 7, 2023 Direct F2
transaction MORF Common Stock Options Exercise $100K +6.67K +39.04% $15.00 23.7K Mar 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -50K -27.18% $0.00 134K Mar 7, 2023 Common Stock 50K $15.00 Direct F3
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -6.67K -4.98% $0.00 127K Mar 9, 2023 Common Stock 6.67K $15.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 862 shares of Common Stock acquired under the Issuer's employee stock purchase plan on February 28, 2023.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The option vested as to 25% of the total shares on April 6, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on April 6, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date.